Neuronetics (STIM) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Neuronetics (STIM) Tops Q2 EPS by 2c

Neuronetics Reports Second Quarter 2022 Financial and Operating Results

August 2, 2022 8:00 AM EDT

MALVERN, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therapies in the world, today announced its financial and operating results for the second quarter of 2022.

Second Quarter 2022 Highlights

Exceeded guidance Second quarter 2022 revenue of $16.3 million, exceeded previously issued guidance of $15.0 million to $16.0 millionIncreased NeuroStar System revenue 70% over the second quarter of 2021 Revenue from 59 NeuroStar Systems... More